E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer

Xinxing Ye, Jie Zhou, Dandan Tong, Dandan Wang, Hui Wang, Jixue Guo, Xinmei Kang

DOI: 10.1155/2022/8168517
Published: 2022-09-17
Container: Disease Markers
Publisher: Wiley
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2022/8168517,
  title = {E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer},
  author = {Xinxing Ye and Jie Zhou and Dandan Tong and Dandan Wang and Hui Wang and Jixue Guo and Xinmei Kang},
  year = {2022},
  journal = {Disease Markers},
  doi = {10.1155/2022/8168517},
  url = {https://doi.org/10.1155/2022/8168517}
}

RIS

TY  - JOUR
TI  - E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer
AU  - Xinxing Ye
AU  - Jie Zhou
AU  - Dandan Tong
AU  - Dandan Wang
AU  - Hui Wang
AU  - Jixue Guo
AU  - Xinmei Kang
PY  - 2022
JO  - Disease Markers
DO  - 10.1155/2022/8168517
UR  - https://doi.org/10.1155/2022/8168517
ER  -

APA

Ye, X., Zhou, J., Tong, D., Wang, D., Wang, H., Guo, J., & Kang, X. (2022). E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer. Disease Markers. https://doi.org/10.1155/2022/8168517

Source records

crossref · retrieved 2026-09-25T07:21:28.290Z